A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
- 30 June 2007
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 46 (6), 1009-1017
- https://doi.org/10.1016/j.jhep.2006.12.017
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Host and donor risk factors before and after liver transplantation that impact HCV recurrenceLiver Transplantation, 2003
- Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis CGut, 2002
- Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipientsHepatology, 2002
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- Hepatitis C and liver transplantationJournal of Hepatology, 2001
- Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantationHepatology, 2000
- Liver Transplantation for Hepatitis C: Recurrence and Disease Progression in 300 PatientsLiver Transplantation, 2000
- Recurrent hepatitis C after liver transplantationJournal of Medical Virology, 2000
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis CGastroenterology, 1999
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationNew England Journal of Medicine, 1996